Genzyme Corporation today announced that the FDA's Orthopaedic and Rehabilitation Devices Advisory Committee voted unanimously (5 - 0) in favor of approval without conditions of Synvisc-One TM (hylan ...
Important Therapy Provides Six Months Pain Relief with Single Injection Genzyme Corporation (Nasdaq: GENZ) today announced that the U.S. Food and Drug Administration (FDA) has granted marketing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results